Atlas Trials

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

Clinical trial NCT04628871 · TERMINATED

Trial details

NCT number
NCT04628871
Sponsor
Sangamo Therapeutics
Status
TERMINATED
Study type
OBSERVATIONAL
Hemophilia BMucopolysaccharidosis IMucopolysaccharidosis II
Start date
2020-11-03
Primary completion
2026-06-17
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.